A phase 1, single-center, placebo-controlled, double-blind study to assess the single dose pharmacokinetics of CC-8490 in healthy volunteers

被引：0

作者：

Scheffler, M ^{[1
]}

Wu, A ^{[1
]}

Teo, S ^{[1
]}

Friedman, G ^{[1
]}

Faleck, H ^{[1
]}

Zeldis, J ^{[1
]}

Stirling, DI ^{[1
]}

Thomas, SD ^{[1
]}

机构：

[1] Celgene Corp, Warren, NJ USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2003年 / 43卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1030 / 1030

页数：1

共 50 条

[1] A single-center, randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, and pharmacokinetics of multiple-ascending doses of pridopidine in healthy volunteers
Osterberg, O.
Ivkovic, J.
Sundgreen, C.
Muglia, P.
Prang, A.
Darpo, B.
NEUROTHERAPEUTICS, 2013, 10 (01) : 175 - 175
[2] Safety, tolerability, pharmacokinetics, and food effect of baicalein tablets in healthy Chinese subjects: A single-center, randomized, double-blind, placebo-controlled, single-dose phase I study
Dong, Ruihua
Li, Lijun
Gao, Hongzhi
Lou, Kun
Luo, Hongmei
Hao, Sheng
Yuan, Jing
Liu, Zeyuan
JOURNAL OF ETHNOPHARMACOLOGY, 2021, 274
[3] A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Intravenous and Subcutaneous Garadacimab (CSL312) in Healthy Subjects
McKenzie, Andrew
Roberts, Anthony
Malandkar, Sourabh
Feuersenger, Henrike
Panousis, Con
Pawaskar, Dipti
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB137 - AB137
[4] A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF OCR-002 IN HEALTHY VOLUNTEERS
Jochelson, P.
van de Wetering, J. L.
Bornstein, J.
Resler, M.
Anderson, K.
JOURNAL OF HEPATOLOGY, 2011, 54 : S70 - S70
[5] THE EFFECT OF APRAGLUTIDE ON GASTRIC EMPTYING IN HEALTHY INDIVIDUALS: A PHASE 1 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, SINGLE-CENTER TRIAL
Greig, Gerard
Youssef, Nader N.
Li, Carrie
Bolognani, Federico
GASTROENTEROLOGY, 2024, 166 (05) : S881 - S881
[6] PHARMACOKINETICS OF LACOSAMIDE IN KOREAN HEALTHY SUBJECTS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE AND REPEATED DOSE STUDY.
Gu, N.
Kim, B. H.
Lee, S.
Kim, T. E.
Fichtner, A.
Elshoff, J.
Yu, K. S.
King, I. J.
Shin, S. G.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S84 - S85
[7] A Randomized, Single-Center, Double-Blind, Placebo-Controlled Multiple-Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Imarikiren in Healthy Adult Nonelderly and Elderly Male Subjects
Matsuno, Kumi
Tanaka, Shingo
Hashimoto, Takamasa
Nakamichi, Hiroyuki
Kagawa, Tomoya
Koumura, Emiko
JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (11): : 1516 - 1524
[8] The Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Ebronucimab in Healthy Volunteers: Result From a Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Dose-Escalation Study
Chen, Rui
Tian, Zhuang
Tang, Xiange
Hu, Pei
Wang, Lvya
Xia, Yu
Li, Baiyong
Wang, Max
Ni, Xiang
Wang, Guoqin
Zhang, Shuyang
CIRCULATION, 2022, 146
[9] A phase I double-blind, placebo-controlled, single rising dose study to determine the safety, tolerability, and pharmacokinetics of oral YM934 in healthy male volunteers
Burggraaf, J
Schoemaker, RC
Terpstra, IJ
Cohen, AF
JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (01): : 45 - 53
[10] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies of the Safety, Tolerability and Pharmacokinetics of Naldemedine in Healthy Volunteers
Fukumura, Kazuya
Yokota, Takaaki
Baba, Yuko
Camilo, Juan
Ferreira, Arjona
GASTROENTEROLOGY, 2016, 150 (04) : S537 - S538

← 1 2 3 4 5 →